Wells Fargo analyst John Kilichowski lowered the firm’s price target on Omega Healthcare (OHI) to $41 from $43 following quarterly results as uncertainty is likely to continue. The firm keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target lowered to $39 from $43 at RBC Capital
- Omega Healthcare Reports Strong 2024 Financial Results
- Omega Healthcare’s Balanced Earnings Call Highlights
- Strong Q4 Performance and Strategic Moves Reinforce Buy Rating for Omega Healthcare
- Omega Healthcare reports Q4 adusted FFO 74, consensus 73c
Questions or Comments about the article? Write to editor@tipranks.com